CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Communiqués Charles River Laboratories International, Inc.

Actions

CRL

US1598641074

Temps réel estimé Cboe BZX Autres places de cotation 18:29:59 11/06/2024			Varia. 5j.	Varia. 1 janv.
210,2 ^USD	-2,01 %		-0,04 %	-11,11 %

07/06	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Mizuho Securities de acheteur à neutre sur le titre	ZM
06/06	Charles River Laboratories ouvre un nouvel espace de vivarium sous contrat dans le Massachusetts	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives	14:03	BU
Charles River Laboratories Expands Access to CRADL Contract Vivarium Space in Somerville	07/06	AQ
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	06/06	BU
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research	04/06	BU
Charles River Laboratories to Present at William Blair and Jefferies Conferences	03/06	BU
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	30/05	BU
Charles River: Q1 Earnings Snapshot	09/05	AQ
Charles River Laboratories Announces First-Quarter 2024 Results	09/05	BU
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP	02/05	BU
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024	24/04	PU
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally	22/04	BU
Charles River Laboratories International : 2023 Corporate Citizenship Report	22/04	PU
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing	16/04	BU
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call	15/04	AQ
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call	12/04	BU
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology	11/04	BU
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics	09/04	BU
Charles River to Perform Plasmid Production for Ship of Theseus	04/04	BU
Charles River to Perform Plasmid Production for Ship of Theseus	04/04	BU
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024	01/04	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Charles River Laboratories International, Inc.

Actions

CRL

US1598641074

Communiqués

Filtres